The Global Elastomeric Infusion Pumps Market Growth Accelerated By Rising Demand For Continuous Drug Delivery

Elastomeric Infusion Pumps Market 

 Elastomeric Infusion Pumps are drug delivery devices used for controlled delivery of medications such as antibiotics, analgesics, chemotherapy drugs, and other drugs. The pumps offer several advantages over traditional infusion methods including ambulatory mobility as they are small, lightweight, and easy to carry or wear.

The global Elastomeric Infusion Pumps Market is estimated to be valued at US$ 446.31 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Technological advancements in elastomeric pump design are expected to be a major trend in the market over the forecast period. Continuous enhancement and development of infusion pump functions by incorporating connectivity, control features, and data sharing capabilities are paving the way for next-generation smart elastomeric pumps. Key players are launching Bluetooth and Wi-Fi enabled pumps that allow wireless programming and monitoring of drug delivery schedules from a smartphone or web portal. This enables real-time patient monitoring and improves compliance to prescribed medication schedules. These smart pumps also allow for over-the-air firmware and software upgrades to enhance their functional abilities over time without requiring physical servicing or visit to a healthcare facility.


Segment Analysis

The global elastomeric infusion pumps market is dominated by patient-controlled analgesia pumps segment. These pumps are small battery-powered infusion devices used during post-operative pain management that allow patients to self-administer pre-set bolus doses of analgesics based on their self-assessed pain levels. Patient-controlled analgesia pumps ensure superior pain relief compared to traditional intermittent scheduled injections, enabling earlier mobilization and a more comfortable recovery process for patients.

Key Takeaways

The global elastomeric infusion pumps market analysis is expected to witness high growth over the forecast period of 2024 to 2031 supported by rising aging population and increasing incidence of chronic diseases worldwide. The global Elastomeric Infusion Pumps Market is estimated to be valued at US$ 446.31 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031.

Regional analysis:

 North America region currently dominates the market owing to rapidly growing geriatric population and higher adoption of advanced medical devices in the region. Europe is also a major market supported by availability of favorable reimbursement policies and healthcare infrastructure. Asia Pacific region is expected to witness fastest growth over the coming years due to improving healthcare access, growing medical tourism industry, and increasing expenditures on healthcare in countries like China and India.

Key players:

Key players operating in the elastomeric infusion pumps market are Sika AG, BASF SE, Fosroc International Limited, Saint-Gobain Weber, The Euclid Chemical Company, Dayton Superior Corporation, WR Meadows, Specified Technologies Inc, TCC Materials and EMSEAL Joint Systems Ltd. These leading manufacturers are focusing on new product launches and expanding regional presence to strengthen their market position.

 Get more insights on this topic: https://www.newswirestats.com/elastomeric-infusion-pumps-market-industry-insights-trends-elastomeric-infusion-pumps-market/




Comments

Popular posts from this blog

The Global Coffee Market Growth Accelerated By Demand From Millennials And Gen Z Population

The Global Ammonium Nitrate Market Growth Accelerated By Rising Demand From Agriculture Industry

The Global Biopharmaceuticals Market Growth Accelerated By Innovation In Product Development